These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35418552)

  • 1. Impact of Low-density Lipoprotein Cholesterol Levels on Outcomes in Nonvalvular Atrial Fibrillation: Results from the China Atrial Fibrillation Registry Study.
    Li ZZ; Du X; Liu N; Guo XY; Jiang C; He L; Xia SJ; Wang W; Tang RB; Chang SS; Yu RH; Long DY; Bai R; Sang CH; Li SN; Dong JZ; Ma CS
    Med Sci Monit; 2022 Apr; 28():e934747. PubMed ID: 35418552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current use of oral anticoagulation therapy and influencing factors among coronary artery disease patients with nonvalvular atrial fibrillation in China].
    Qiao Y; Wang Y; Li SN; Jiang CX; Sang CH; Tang RB; Long DY; Wu JH; He L; Du X; Dong JZ; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 May; 51(5):504-512. PubMed ID: 37198122
    [No Abstract]   [Full Text] [Related]  

  • 3. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
    Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of oral anticoagulants and its associated factors among nonvalvular atrial fibrillation patients with new-onset acute ischemic stroke: A report from the China Atrial Fibrillation Registry study.
    Wang JR; Du X; Dong JZ; Chang SS; Jiang C; Sang CH; Long DY; Tang RB; Zhang HB; Guo JC; Wen YM; He L; Ma CS
    Clin Cardiol; 2022 Jan; 45(1):60-67. PubMed ID: 34952974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LDL Cholesterol and Ischemic Stroke in Patients with Nonvalvular Atrial Fibrillation.
    Omelchenko A; Hornik-Lurie T; Gabay H; Minha S; Assali A; Pereg D
    Am J Med; 2021 Apr; 134(4):507-513. PubMed ID: 33002488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Blood Pressure Control on Thromboembolism and Major Hemorrhage in Patients With Nonvalvular Atrial Fibrillation: A Subanalysis of the J-RHYTHM Registry.
    Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Otsuka T; Tomita H; Origasa H;
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27620886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of oral anticoagulants and related factors among new-onset acute ischemic stroke patients with nonvalvular atrial fibrillation: A report from the China Atrial Fibrillation Registry Study].
    Wang JR; Du X; He L; Dong JZ; Zhang HB; Guo JC; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Sep; 50(9):900-906. PubMed ID: 36096708
    [No Abstract]   [Full Text] [Related]  

  • 8. Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation: The Chinese Atrial Fibrillation Registry Study.
    Chang SS; Dong JZ; Ma CS; Du X; Wu JH; Tang RB; Xia SJ; Guo XY; Yu RH; Long DY; Bai R; Liu N; Sang CH; Jiang CX; Liu XH; Pan JH; Lip GY
    Stroke; 2016 Jul; 47(7):1803-10. PubMed ID: 27283198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF).
    Sun Y; Zhu J; Ma C; Liu S; Yang Y; Hu D
    Cardiovasc Ther; 2019; 2019():7372129. PubMed ID: 31772614
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
    Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
    Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Addition of a Statin to Warfarin on Thromboembolic Events in Japanese Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus.
    Kumagai N; Nusser JA; Inoue H; Okumura K; Yamashita T; Kubo T; Kitaoka H; Origasa H; Atarashi H;
    Am J Cardiol; 2017 Jul; 120(2):230-235. PubMed ID: 28532776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The thromboembolism risk of low-risk atrial fibrillation patients with different clinical characteristics].
    Liu XB; Jia ZX; Xia SJ; He L; Lu SX; Guo XY; Li SN; Liu N; Jiang CX; Sang CH; Tang RB; Long DY; Yu RH; Bai R; Wu JH; Du X; Dong JZ; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):735-739. PubMed ID: 32957755
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic risk.
    Verbrugge FH; Martin AC; Siegal D; Pieper K; Illingworth L; Camm AJ; Fox KAA
    Heart; 2020 Jun; 106(11):845-851. PubMed ID: 31806700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nonvalvular atrial fibrillation: data from the Observatory of Cardiovascular Diseases in the province of Trieste (Italy)].
    Mazzone C; Carriere C; Grande E; Iorio AM; Barbati G; Zecchin M; Serdoz LV; Cioffi G; Tarantini L; Sinagra G; Scardi S; Di Lenarda A
    G Ital Cardiol (Rome); 2015 Jun; 16(6):361-72. PubMed ID: 26156697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    Cullen MW; Kim S; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Singer DE; Mahaffey KW; Kowey PR; Thomas L; Go AS; Lopes RD; Chang P; Peterson ED; Gersh BJ;
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):461-9. PubMed ID: 23759473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery and Patients With Nonvalvular Atrial Fibrillation.
    Butt JH; Xian Y; Peterson ED; Olsen PS; Rørth R; Gundlund A; Olesen JB; Gislason GH; Torp-Pedersen C; Køber L; Fosbøl EL
    JAMA Cardiol; 2018 May; 3(5):417-424. PubMed ID: 29590304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hypertrophic cardiomyopathy on the prediction of thromboembolism in patients with nonvalvular atrial fibrillation.
    Tsuda T; Hayashi K; Fujino N; Konno T; Tada H; Nomura A; Tanaka Y; Sakata K; Furusho H; Takamura M; Kawashiri MA; Yamagishi M;
    Heart Rhythm; 2019 Jun; 16(6):829-837. PubMed ID: 30503962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Olesen JB; Fauchier L; Lane DA; Taillandier S; Lip GYH
    Chest; 2012 Jan; 141(1):147-153. PubMed ID: 21680645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA2DS2-VASc score.
    Yan S; Li Q; Xia Z; Yan S; Wei Y; Hong K; Wu Y; Li J; Cheng X
    Medicine (Baltimore); 2019 Feb; 98(8):e14549. PubMed ID: 30813164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cardiovascular implantable electronic devices in delivering individualized disease-guided management of patients with non-valvular atrial fibrillation and high bleeding risk.
    Mascarenhas DAN; Sharma M; Ziegler PD; Kantharia BK
    Acta Cardiol; 2019 Apr; 74(2):131-139. PubMed ID: 29863432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.